Evidence map›Paper›PMID 32131741›Full record

ArticleBMC microbiology2020

Oral rinses in growth inhibition and treatment of Helicobacter pylori infection.

Dharmendra Kashyap, Budhadev Baral, Tarun Prakash Verma, Charu Sonkar, Debi Chatterji, Ajay Kumar Jain, Hem C Jha

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. The role ofHeliyon · 2024
    Article
  5. Helicobacter pylori in oral cavity: current knowledge.Clinical and experimental medicine · 2024
    Review
  6. Article
  7. Review
  8. Genes & diseases · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dharmendra KashyapDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, 453552, Indore, Madhya Pradesh, India.
Budhadev BaralDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, 453552, Indore, Madhya Pradesh, India.
Tarun Prakash VermaDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, 453552, Indore, Madhya Pradesh, India.
Charu SonkarDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, 453552, Indore, Madhya Pradesh, India.
Debi ChatterjiChoithram Hospital and Research Centre, 452014, Indore, Madhya Pradesh, India.
Ajay Kumar JainChoithram Hospital and Research Centre, 452014, Indore, Madhya Pradesh, India.
Hem C JhaDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, 453552, Indore, Madhya Pradesh, India. hemcjha@iiti.ac.in.
Indian Institute of Technology Indore · INChoithram Hospital and Research Centre · IN

Funding

Council of Scientific and Industrial Research, India 37(1693)/17/EMR-IIDepartment of Science and Technology, Ministry of Science and Technology EMR/2017/001637.Department of Science and Technology, Ministry of Science and Technology SB/S2/RJN-132/20/5
6 · The paper itself

Abstract

backgroundHelicobacter pylori (H. pylori) is well-known for its role in chronic gastritis and gastric cancer. Eradication of these carcinogenic bacteria from the gut is one of the challenges for clinicians. The complexity of treatment mainly owes to antibiotic resistance and relapse due to an additional reservoir in the oral cavity. Our study emphases the isolation of H. pylori from distinct habitats of the gut microenvironment (gastric biopsy and gastric juice) and its subsequent characterization. We have also evaluated the effect of various oral rinses on isolated H. pylori from different anatomical locations of included subjects.

resultsThe possible strains isolated from two different habitats of the same subject shows a striking difference in their growth pattern. Promisingly, some of the included oral rinses are efficient in growth inhibition as per recommended 30 s treatment. The subsequent evaluation shows that oral rinse B (among A-E) is most effective and down-regulates the expression of one of the potent H. pylori gene, CagA, in the infected gastric adenocarcinoma (AGS) cells.

conclusionOur study, for the first time, revealed that H. pylori, isolated from the different habitat of the same subject, show a different growth pattern. The expression of H. pylori pathogenic gene (CagA) was down-regulated by the use of oral rinses. Hence, oral rinses will reduce the H. pylori in the oral cavity and help to control its migration from oral to the gastric compartment and may be used as an adjuvant treatment option for its re-infection.

Indexed as

Antigens, BacterialBacterial ProteinsBiopsyCell Line, TumorDown-RegulationFemaleGastric JuiceGastric MucosaGene Expression Regulation, BacterialHelicobacter InfectionsHelicobacter pyloriHumansMaleMicrobial ViabilityMouthMouthwashesAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriMouthwashesRNA, Ribosomal, 16SApoptotic pathwayCagAGastric cancerGastritisGrowth curveH. pyloriOral rinses

Identifiers

PMID32131741
PMCPMC7055109
OpenAlexW3012188490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.